InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,408.42
(
-1.73%
)
US TECH 100
17,870.94
(
-3.09%
)
Dow Jones
40,345.41
(
-1.01%
)
Brent Oil
70.89
(
0.00%
)
Bitcoin
54,469.32
(
0.54%
)
Post# of 38096
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jedijazz

Send PM Follow Ignore
Followers 1329
Posts 250272
Boards Moderated 52
Alias Born 12/07/2009

jedijazz

Member Level

Re: None

Wednesday, 11/08/2017 3:05:39 PM

Wednesday, November 08, 2017 3:05:39 PM

Post# of 38096
$ENTB Entest BioMedical Inc. is the parent company of Zander Therapeutics Inc. The focus of Zander Therapeutics, Inc. is to develop small molecule immunotherapies and cancer stem cell therapies for the veterinary market.

$ENTB is specifically focused on animal therapies that address unmet medical needs. Zander is looking to increase the quality of life in animals through therapies involving small molecules, stem cell treatments and the body’s own immune system.

These treatments are focused in areas relating to lung, heart, circulatory system and other internal organs. http://www.frontpagestocks.com/entest-biomedical-inc-entb/


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up